Jenburkt Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited scores highest on Price (91) and lowest on Nitro (46). Its PosiPenta is 70.43 out of 100, better than most similar companies.
On the Penta Grid this week, Jenburkt Pharmaceuticals Limited is Grid #3 of 168 in the Healthcare sector in India, and Grid #42 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Jenburkt Pharmaceuticals Limited | 70.43 | 91 | 90 | 46 | 77 | 48 |
| Medicamen Biotech Limited | 39.21 | 72 | 43 | 20 | 32 | 29 |
| Aarey Drugs & Pharmaceuticals Limited | 39.35 | 48 | 16 | 99 | 20 | 13 |
| Albert David Limited | 68.84 | 90 | 76 | 81 | 43 | 54 |
| QMS Medical Allied Services Limited | 46.39 | 69 | 37 | 59 | 24 | 44 |
| Haleos Labs Limited | 60.12 | 77 | 83 | 68 | 21 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 12.41 |
| P/B ratio | 2.07 |
EEarnings
| Trailing EPS | ₹74.39 |
| Forward EPS | — |
NNitro
| Price | 923.45 |
| 52-week high | 1073.90 |
| 52-week low | 864.00 |
| Fall from 52-week high | 14.0% |
TTorque
| Return on equity (ROE) (calculated) | 16.66% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.39 |
| Market cap | ₹407 Cr |
| Promoter holding | 46.62% |
| Dividend yield | 2.25% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Jenburkt Pharmaceuticals Limited's PosiPenta score?
Jenburkt Pharmaceuticals Limited's PosiPenta is 70.43 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Jenburkt Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Jenburkt Pharmaceuticals Limited is Grid #3 of 168 in the Healthcare sector in India, and Grid #42 of 2,356 in India.
Which PosiPenta pillar is strongest for Jenburkt Pharmaceuticals Limited?
Price (valuation), with a score of 91 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Jenburkt Pharmaceuticals Limited?
Nitro (momentum), with a score of 46 out of 100: around the middle of similar companies.
Has Jenburkt Pharmaceuticals Limited's PosiPenta changed since last week?
Yes, it fell 3.97 points, from 74.40 to 70.43.
PositoAI is for research and education only and is not investment advice.